APLLTD - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.3
| Stock Code | APLLTD | Market Cap | 15,701 Cr. | Current Price | 798 ₹ | High / Low | 1,108 ₹ |
| Stock P/E | 35.4 | Book Value | 267 ₹ | Dividend Yield | 1.38 % | ROCE | 11.3 % |
| ROE | 9.68 % | Face Value | 2.00 ₹ | DMA 50 | 826 ₹ | DMA 200 | 901 ₹ |
| Chg in FII Hold | 0.19 % | Chg in DII Hold | -0.13 % | PAT Qtr | 179 Cr. | PAT Prev Qtr | 104 Cr. |
| RSI | 49.5 | MACD | -14.2 | Volume | 39,343 | Avg Vol 1Wk | 37,374 |
| Low price | 725 ₹ | High price | 1,108 ₹ | PEG Ratio | -10.7 | Debt to equity | 0.27 |
| 52w Index | 19.0 % | Qtr Profit Var | 15.6 % | EPS | 22.6 ₹ | Industry PE | 29.1 |
📊 Analysis: APLLTD is trading at ₹798, below its 50 DMA (₹826) and 200 DMA (₹901), reflecting short-term weakness. RSI at 49.5 indicates neutral momentum, while MACD (-14.2) shows bearish crossover. Intraday volume (39,343) is slightly above the weekly average (37,374), suggesting moderate participation. Fundamentals show improvement in quarterly PAT (₹179 Cr. vs ₹104 Cr., +15.6%), but relatively low ROCE (11.3%) and ROE (9.68%) limit efficiency. Valuation is stretched with P/E (35.4 vs industry 29.1), though dividend yield (1.38%) adds some investor appeal.
💡 Optimal Buy Price: ₹785–790 if price consolidates near support.
🎯 Profit-Taking Levels: ₹815–820 (near 50 DMA resistance).
🛡️ Stop-Loss: ₹775 to protect against downside risk.
⏱️ Exit Strategy (if already holding): Exit if price fails to sustain above ₹815 with strong volume. Weak momentum and bearish MACD suggest booking profits early rather than holding for extended moves.
Positive
- Quarterly PAT growth from ₹104 Cr. to ₹179 Cr. (+15.6%).
- EPS of ₹22.6 supports earnings visibility.
- Dividend yield of 1.38% provides investor returns.
- FII holding increased slightly (+0.19%), showing foreign confidence.
Limitation
- Trading below both 50 DMA and 200 DMA, showing bearish trend.
- Low ROCE (11.3%) and ROE (9.68%) highlight weak efficiency.
- P/E of 35.4 is higher than industry average (29.1).
- Negative PEG ratio (-10.7) indicates valuation concerns.
Company Negative News
- No major negative news reported, but efficiency metrics remain weak.
Company Positive News
- Quarterly profit growth indicates earnings momentum.
- Dividend yield and EPS provide investor confidence.
Industry
- Industry P/E at 29.1 suggests sector is moderately valued.
- Pharmaceutical sector benefiting from healthcare demand and expansion opportunities.
Conclusion
⚖️ APLLTD shows improving earnings but weak intraday momentum and stretched valuations. It is a moderate candidate for intraday trading with entry near ₹785–790 and profit-taking around ₹815–820. Traders should closely monitor volume and momentum indicators before committing to positions.